학술논문

Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: Sixteen-Week Results From a Phase III Randomized, Double-Blind, Placebo-Controlled Trial in Patients With Prior Inadequate Response to or Intolerance of Tumor Necrosis Factor Inhibitors
Document Type
Article
Source
In: Arthritis and Rheumatology. (Arthritis and Rheumatology, April 2019, 71(4):599-611)
Subject
Language
English
ISSN
23265205
23265191